Cellid, Co., Ltd. (KOSDAQ:299660)
3,230.00
+140.00 (4.53%)
Apr 29, 2026, 3:30 PM KST
Cellid, Market Cap
Cellid, has a market cap or net worth of 91.16 billion as of April 29, 2026. Its market cap has increased by 23.08% in one year.
Market Cap
91.16B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3,230.00
Market Cap Chart
Since February 20, 2019, Cellid,'s market cap has decreased from 482.44B to 91.16B, a decrease of -81.10%. That is a compound annual growth rate of -20.69%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 69.85T |
| Celltrion | 42.76T |
| ALTEOGEN | 20.28T |
| Samsung Epis Holdings | 14.08T |
| IMB Dx | 101.21B |
| Kukje Pharma | 97.74B |
| Humasis | 90.64B |
| GeneOne Life Science | 88.23B |